Skip to main content
Premium Trial:

Request an Annual Quote

Whitaker Foundation Awards UC Davis $12M to Support Genomics and Biomedical Sciences

NEW YORK, July 30 - The Whitaker Foundation said Monday that it has awarded a grant of $12 million to the new Department of Biomedical Engineering at the University of California, Davis. Of the total grant, $10 million has been earmarked to help fund the university’s new Genome and Biomedical Sciences building, scheduled to be completed in 2004. 

The grant could trigger an additional $35 million in total matching funds from the state government and university sources. 

The Department of Biomedical Engineering at UC Davis was established within the College of Engineering in February. The department intends to focus its initial efforts on genomics, with the development of mathematical tools and computer programs to analyze genomic sequence data among its first goals.

Craig Benham, recently appointed as associate director and current interim director of the UC Davis Genome Center, will have a faculty position in the department, which currently has six faculty members. The university plans to hire another 10 faculty over the next five years.

Whitaker Foundation spokesman Frank Blanchard said that a major factor in awarding the grant was UC Davis' plan to bring together genomics and studies of whole organs. "The department has a very well-developed plan led by a clear vision for the future," said Blanchard.

In addition to its genomics research, the department will also develop microinstruments for medical use and study the fluid dynamics in blood.  

The Whitaker Foundation establishes competitive grant programs to support interdisciplinary medical research, with a primary focus on biomedical engineering. It has contributed more than $450 million to universities and medical schools in the United States and Canada since its inception in 1975.


The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.